Literature DB >> 24102397

Primary malignant tumours of the bony pelvis: US-guided high intensity focused ultrasound ablation.

Yang Wang1, Wei Wang, Jie Tang.   

Abstract

PURPOSE: The aim of this review is to evaluate the value of ultrasound (US)-guided high intensity focused ultrasound (HIFU) ablation in the treatment of primary malignant tumours of the bony pelvis.
MATERIALS AND METHODS: Eleven patients with primary malignant tumours of the bony pelvis received US-guided HIFU ablation. The maximum tumour size ranged from 5.6 to 25.0 cm (median 10.5 cm). Treatment was curative in four patients and palliative in seven patients. During follow-up, the effectiveness of HIFU ablation was assessed by contrast-enhanced magnetic resonance (MR).
RESULTS: Significant coagulative necrosis was obtained in all patients after scheduled HIFU ablations; the volume ablation ratio was 86.7% ± 12.5% (range 65-100%). Complete tumour necrosis was achieved in all patients receiving curative HIFU ablation. No major complications were encountered. No patients died of local tumour progression during follow-up.
CONCLUSIONS: US-guided HIFU ablation may be a safe and effective minimally invasive technique for the local treatment of primary malignant tumours of the bony pelvis.

Entities:  

Mesh:

Year:  2013        PMID: 24102397     DOI: 10.3109/02656736.2013.840806

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  3 in total

Review 1.  MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.

Authors:  Alberto Bazzocchi; Alessandro Napoli; Beatrice Sacconi; Giuseppe Battista; Giuseppe Guglielmi; Carlo Catalano; Ugo Albisinni
Journal:  Br J Radiol       Date:  2015-11-26       Impact factor: 3.039

2.  Interstitial ultrasound ablation of vertebral and paraspinal tumours: parametric and patient-specific simulations.

Authors:  Serena J Scott; Vasant Salgaonkar; Punit Prakash; E Clif Burdette; Chris J Diederich
Journal:  Int J Hyperthermia       Date:  2014-06       Impact factor: 3.914

3.  Thermochemical ablation therapy of VX2 tumor using a permeable oil-packed liquid alkali metal.

Authors:  Ziyi Guo; Qiang Zhang; Xiaoguang Li; Zhengyu Jing
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.